Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CDK2/Cyclin E1 HTRF Enzyme Activity Assay from US Patent US11919904: "Sulfonylamide compounds as CDK2 inhibitors"
Assay data:14 Active, 14 Activity ≤ 1 µM, 14 Tested
SummaryRelated BioAssays by Target
In Vitro Test of Activities of Jak1, Jak2, Jak3, Tyk2 Kinases from US Patent US11919896: "[1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and use thereof"
Assay data:34 Active, 34 Activity ≤ 1 µM, 34 Tested
In Vitro JAK Kinase Assay from US Patent US11918581: "Combination therapy comprising JAK pathway inhibitor and rock inhibitor"
Assay data:26 Active, 26 Activity ≤ 1 µM, 26 Tested
FRET based assay from US Patent US11912660: "S6K1 protein kinase inhibitors as cancer therapeutics"
Assay data:2 Active, 3 Tested
In Vitro JAK Kinase Assay from US Patent US20240058343: "TREATMENT OF URTICARIA USING JAK INHIBITORS"
TBD from US Patent US20240034743: "TRICYCLIC COMPOUNDS AS EGFR INHIBITORS"
Assay data:135 Active, 118 Activity ≤ 1 nM, 137 Activity ≤ 1 µM, 137 Tested
Assay data:133 Active, 31 Activity ≤ 1 nM, 137 Activity ≤ 1 µM, 137 Tested
CDK2/Cyclin E1 Full length ADP-Glo Kinase Assay from US Patent US20240034731: "AZA-QUINAZOLINE COMPOUNDS AND METHODS OF USE"
Assay data:95 Active, 92 Activity ≤ 1 µM, 97 Tested
CDK1/Cyclin B1 ADP-Glo Kinase Assay from US Patent US20240034731: "AZA-QUINAZOLINE COMPOUNDS AND METHODS OF USE"
Assay data:75 Active, 1 Activity ≤ 1 nM, 52 Activity ≤ 1 µM, 99 Tested
Assay for Inhibition of CDK2/CyclinE1 from US Patent US20240033264: "CDK INHIBITORS"
Assay data:4 Active, 4 Activity ≤ 1 µM, 4 Tested
NanoBRET assay (JAK1, SGC Frankfurt)
Assay data:2 Tested
NanoBRET (AKT3)
Assay data:1 Active, 1 Activity ≤ 1 µM, 2 Tested
AKT3 SGC Tm panel (DSF)
Assay data:1 Tested
MAPK9 SGC Tm panel (DSF)
MAPK8 SGC Tm panel (DSF)
MAPK14 SGC Tm panel (DSF)
MAPK13 SGC Tm panel (DSF)
MAPK10 SGC Tm panel (DSF)
MAP2K6 SGC Tm panel (DSF)
MAP2K1 SGC Tm panel (DSF)
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on